Opportunities
Search

The U.S. Wildland Fire Service Joint Fire Science Program (JFSP) is seeking to solicit proposals to lead and execute regional fire science exchanges in specific regions for a period of two years. Proposals are requested for the following nine regions of the FSEN: Alaska, Appalachians, Great Basin, North Atlantic, Northern Rockies, Northwest, Oak Woodlands, Pacific Islands and Southwest. Individual proposals (i.e., each proposal must be specific to one region) are requested to lead and execute a regional fire science exchange in the requested specific regions for a period of two years.   Please consult the JFSP database for the specific requirements on each individual task statement, https://www.firescience.gov/ All proposals must be submitted by September 17, 2026, 5:00 pm MT, using the electronic submission process provided by the JFSP website (https://www.firescience.gov).  Proposals cannot be submitted through Grants.gov. No exceptions are allowed to this closing date or time.

The U.S. Wildland Fire Service Joint Fire Science Program is soliciting proposals in two topic areas: (1) drivers of changing wildfire regimes and consequences for wildfire risk factors and (2) smoke impacts from prescribed fire and wildfire. 1.     Drivers of changing wildfire regimes and consequences for wildfire risk factors The objective of this task statement is to increase understanding of the drivers and consequences of changing wildfire regimes to inform future management and monitoring plans that accelerate adaptation to these altered regimes that reduce wildland fire risk factors. JFSP is asking potential investigators to address the following research needs in this task statement. Potential investigators must address all three research needs to be considered responsive to the task statement. ·      Research that leads to improved models, datasets, or other tools to more accurately forecast future fire regimes and consequences for ecosystems and valued resources (e.g., communities, infrastructure, municipal watersheds). ·      In collaboration with fire and land managers, use of improved models, datasets, or other tools to explore scenarios of future fire regimes and consequences for ecosystems and valued resources, identify potential tipping points, and feedback mechanisms for accelerated change. ·      In collaboration with fire and land managers, devise potential monitoring protocols to detect potential tipping points or other indicators of change.     2.     Smoke impacts from prescribed fire and wildfire The objectives of this task statement are 1) to better....

Objective:The ERC Proof of Concept Grants aim at facilitating exploration of the commercial and social innovation potential of ERC funded research and are therefore available only to Principal Investigators whose proposals draw substantially on their ERC funded research.Scope:Size of ERC Proof of Concept Grants: The financial contribution will be awarded as a single lump sum of EUR 150 000 for a period of eighteen months. Extensions of the duration of Proof of concept projects may be granted only exceptionally.The lump sum will cover the beneficiaries' direct and indirect eligible costs for the project: if the project is implemented properly the amounts will be paid regardless of the costs actually incurred. The lump sum is designed to cover the beneficiaries’ personnel costs, subcontracting costs, purchase costs, other cost categories, and indirect costs.Profile of the ERC Proof of Conc...

Scope:The objective of the European mini-slate development support is to foster the competitiveness of European independent production companies and to increase their economic weight on the market. The aim is also to increase the capacity of audiovisual producers to develop projects with the potential to circulate throughout Europe and beyond, and to facilitate European and international coproduction.The support will also provide an entry point for emerging talent, giving them the opportunity to direct a short film supported by the strong foundation provided by experienced companies.Expected resultsA stronger position on European and international markets for companies selected under European slate development.Increased quality, feasibility, cross-border potential and market value of European works supported. Description of the activities to be fundedSupport will be given to independent...

The Division of Mathematical Sciences (DMS)in the Directorate for Mathematical and Physical Sciences (MPS) at the National Science Foundation (NSF)and the National Institute of General Medical Sciences (NIGMS) at the National Institutes of Health (NIH)plan to support fundamental research in mathematics and statistics necessary to answer questions in the biological and biomedical sciences. Both agencies recognize the need to promote research at the interface between mathematical and life sciences. This program is designed to encourage new collaborations, as well as to support innovative activities by existing teams. The joint DMS/NIGMS initiative offers two submission tracks: Track 1 - for projects with a total budget of up to $600,000 for an award duration of 3 years, and Track 2 - for projects with a total budget of up to $1,200,000 for an award duration of 3-4 years.

This Notice of Funding Opportunity (NOFO) is one of three NOFOs for the National Cancer Institute (NCI) Community Oncology Research Program (NCORP). NCORP is designed to enhance generalizability and dissemination of clinical trial and other human subject research study results through accrual in a variety of community settings. The purpose of NCORP is to engage cancer patient populations, those at risk of cancer, and organizations in rigorous studies focused on cancer control, prevention, treatment and care delivery.NCORP is a community-based research network that:Designs and conducts clinical trials and other human subject studies for adults and children in cancer control, prevention, screening, and care delivery, as well as quality-of-life studies embedded within treatment trials;Enhances patient and provider access to treatment and imaging trials conducted under the National Clinical Trials Network (NCTN);NCORP will support the following components that will be individually awarded through the respective Request for Applications (RFAs) indicated below:NCORP Research Bases (UG1 Clinical Trials Required)(covered by this NOFO);NCORP Community Sites (UG1 Clinical Trials Not Allowed); andNCORP Academic Community Sites (UG1 Clinical Trials Not Allowed).NCORP Research Bases will serve as the program's research hubs and are expected to:Provide an established organizational structure, with scientific and statistical leadership for developing, implementing, and analyzing multi-institutional cancer control, prevention, and care delivery (CCP&CD) clinical research, as well as qualit...

This Notice of Funding Opportunity (NOFO) is one of three NOFOs for the National Cancer Institute (NCI) Community Oncology Research Program (NCORP). NCORP is designed to enhance generalizability and dissemination of clinical trial and other human subject research study results through accrual in a variety of community settings. The purpose of NCORP is to engage cancer patient populations, those at risk of cancer, and organizations in rigorous studies focused on cancer control, prevention, treatment and care delivery.NCORP is a community-based research network that:Designs and conducts clinical trials and other human subject studies for adults and children in cancer control, prevention, screening, and care delivery, as well as quality-of-life studies embedded within treatment trials;Enhances patient and provider access to treatment and imaging trials conducted under the National Clinical Trials Network (NCTN)NCORP will support the following components that will be individually awarded through the respective Request for Applications (RFAs) indicated below:NCORP Research Bases (UG1 Clinical Trials Required);NCORP Community Sites (UG1 Clinical Trials Not Allowed)(covered by this NOFO); andNCORP Academic Community Sites (UG1 Clinical Trials Not Allowed).The NCORP Community Sites is a healthcare system, a consortium of healthcare systems, or a consortia of community hospitals and/or oncology practices, public hospitals, and/or health care centers that can enhance the representativeness of participants accrued to cancer control, prevention, treatment and care delivery clinical tri...

This Notice of Funding Opportunity (NOFO) is one of three NOFOs for the National Cancer Institute (NCI) Community Oncology Research Program (NCORP). NCORP is designed to enhance generalizability and dissemination of clinical trial and other human subject research study results through accrual in a variety of community settings. The purpose of NCORP is to engage cancer patient populations, those at risk of cancer, and organizations in rigorous studies focused on cancer control, prevention, treatment and care delivery.NCORP is a community-based research network that:Designs and conducts clinical trials and other human subject studies for adults and children in cancer control, prevention, screening, and care delivery, as well as quality-of-life studies embedded within treatment trials;Enhances patient and provider access to treatment and imaging trials conducted under the National Clinical Trials Network (NCTN);NCORP will support the following components that will be individually awarded through the respective Request for Applications (RFAs) indicated below:NCORP Research Bases (UG1 Clinical Trials Required);NCORP Community Sites (UG1 Clinical Trials Not Allowed); andNCORP Academic Community Sites (UG1 Clinical Trials Not Allowed)(covered by this NOFO)NCORP Academic Community Sites are a consortium led by an academic center with a network of community hospitals and/or oncology practices, public hospitals, and/ or other healthcare centers that serve a patient population that can enhance the representativeness of participants accrued to cancer control, prevention, treatment and....

Summary: The fiscal year 2026 (FY26) Duchenne Muscular Dystrophy Research Program (DMDRP) Clinical/Translational Research Award (CTRA) supports advanced translational research to accelerate promising ideas in Duchenne muscular dystrophy (DMD) research toward clinical applications. Research must address at least one of the FY26 CTRA Focus Areas. Research projects investigating therapies that will be efficacious across the life span are strongly encouraged.Distinctive Features: The FY26 CTRA offers two funding levels:• Funding Level 1 to support smaller, less complex preclinical and/or clinical research.• Funding Level 2 to support larger, more complex preclinical and/or clinical research.The FY26 CTRA also offers a Partnering PI Option (PPIO) to support meaningful and productive partnerships between two investigators collaborating on the proposed research project. The PPIO has two eligibility categories:• Early-Career Partnering PI category for an independent, early-career investigator within 10 years of their first faculty appointment (or equivalent) by the time of application submission.• Established Interdisciplinary Partnering PI for independent investigators at all academic levels, or equivalent, in an area other than muscular dystrophy, seeking to transition to a career in DMD, thereby bringing their expertise to the field.Preliminary data are required for all applications. Pilot clinical trials and clinical trial readiness studies to better inform development of drugs, devices, and other interventions are allowed.

Summary: The fiscal year 2026 (FY26) Duchenne Muscular Dystrophy Research Program (DMDRP) Idea Development Award (IDA) promotes new ideas that are still in the early stages of development and have the potential to yield impactful data and new avenues of investigation. This award supports impactful, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for individuals with Duchenne muscular dystrophy (DMD) in the near term. Applications should include a well-formulated, testable hypothesis based on strong scientific rationale. The DMDRP strongly encourages research projects investigating therapies designed to demonstrate efficacy cross the life span, including infants, toddlers and nonambulatory individuals.Distinctive Features: The FY26 DMDRP IDA mechanism offers three eligibility career categories:• The Established Investigator category is for independent investigators at all academic levels, or equivalent• The New Investigator – Early-Stage category is for independent investigators early in their careers (i.e., within 10 years of their first faculty appointment or equivalent). Applicants in this category will be reviewed separately from Established Investigators.• The New Investigator – Transitioning category is for independent investigators at all academic levels, or equivalent, in an area other than muscular dystrophy who are seeking to transition to a career in DMD, thereby bringing their expertise to the field. Applicants in this category will be reviewed separately from Establi...

The Combinatorics program supports research on discrete structures and includes algebraic, enumerative, existential, extremal, geometric, and probabilistic combinatorics, including graph theory. Conferences Principal Investigators should carefully read the program solicitation "Conferences and Workshops in the Mathematical Sciences" (link below) to obtain important information regarding the substance of proposals for conferences, workshops, summer/winter schools, and similar activities. Conference proposals must be submitted at least six months in advance of the conference, and in the same fiscal year (which begins October 1) if possible.

The program in Foundations supports research in mathematical logic and the foundations of mathematics, including proof theory, recursion theory, model theory, set theory, and infinitary combinatorics. Conferences Principal Investigators should carefully read the program solicitation "Conferences and Workshops in the Mathematical Sciences" (link below) to obtain important information regarding the substance of proposals for conferences, workshops, summer/winter schools, and similar activities. Conference and workshop proposals should be submitted eight months before the requested start date.

Summary: The fiscal year 2026 (FY26) Peer Reviewed Medical Research Program (PRMRP) Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have significant impact on the treatment and management of a disease or condition addressed in one of the congressionally directed FY26 PRMRP topic areas and FY26 PRMRP strategic goals.Distinctive Features: Must support a clinical trial. Supports two different application categories, based on the phase of planning for the clinical trial: Clinical Trial Only or Clinical Trial with Planning Phase. The Clinical Trial with Planning Phase option is intended to support the final phase of regulatory activities and planning activities that are necessary to be completed prior to initiation of the clinical trial. The planning phase cannot be used to finalize the intervention or support animal studies. Applications that already have regulatory approvals in place and are submitting to the Clinical Trial Only option may be prioritized over those requesting the Planning Phase option. Animal studies are not supported. Studies must complete all preclinical empirical laboratory work prior to the award start date.Supports three funding levels, each offered with and without a Planning Phase:Funding Level 1: Supports phase 0 or phase 1 clinical trials or non-phased trials with fewer than 100 participants.Funding Level 2: Supports phase 2 clinical trials or non-phased trials with fewer than 300 participants.Funding Level 3: Supports phase 3 clinical trials or non-phased trials with more than 300 participants.Funding D...

Summary: The fiscal year 2026 (FY26) Peer Reviewed Medical Research Program (PRMRP) Platform Clinical Translation Award supports the translational development and/or early-phase clinical trials for broadly applicable clinical technologies that will address urgent and complex needs related to two congressionally directed FY26 PRMRP topic areas. The platform product in development should address one of the FY26 PRMRP portfolio-specific strategic goals and address the health care needs of military Service Members, Veterans and their Families.Distinctive Features:Allows for multiple Principal Investigators (PIs). The proposed experiments may represent a single project led by a single PI, or it may consist of partnerships between principal investigators that will occur synergistically to advance a platform product. One PI will be identified as the Initiating PI and will be responsible for the majority of the administrative tasks associated with application submission. Up to two additional PIs can be identified as Partnering PIs. If recommended for funding, each PI will be named on separate awards to the recipient organization(s).Requires a PI-convened external advisory board with patient advocate participation. The patient advocate must be a person living with, or a family member or caretaker of someone with, a disease or condition addressed in one of the applicant-selected congressionally directed FY26 PRMRP topic areas.Funding Details: The Congressionally Directed Medical Research Programs (CDMRP) expects to allot roughly $30M to fund approximately two Platform Clinical Transl...

Summary: The fiscal year 2026 (FY26) Neurofibromatosis Research Program (NFRP) Neurofibromatosis Research Academy – Scholar Award (NFRA-SA) supports early-career independent investigators (Scholars) joining the Neurofibromatosis Research Academy to pursue a neurofibromatosis project that may include basic, translational, and/or clinical research. The proposed research should address at least one of the FY26 NFRP Areas of Emphasis, under the leadership of the NFRA Director and Deputy Director. The overarching goal of the NFRA is to conduct innovative and impactful research in the field of neurofibromatosis disorders while developing successful, highly productive NF researchers in a collaborative research and career development environment.Distinctive Features:• Scholar: The Scholar, named as the Principal Investigator, must be less than 10 years of completion of their terminal degree by the time of the application deadline (excluding time spent in residency, clinical training, or on family medical leave).• Career Guide: This award mechanism requires each Scholar to designate a Career Guide for guidance. The Career Guide is not required to be at the same institution as the Scholar; however, if the (primary) Career Guide is from a different institution, the application must identify a secondary Career Guide at the Scholar’s institution.

Summary: The fiscal year 2026 (FY26) Neurofibromatosis Research Program (NFRP) Investigator-Initiated Research Award (IIRA) supports high-impact research that addresses a critical need and has the potential to make important contributions to the field of neurofibromatosis disorders or advance patient care. Research projects may focus on any phase of research, excluding clinical trials. The rationale for a research idea may be derived from laboratory discovery, population-based studies, a clinician’s firsthand knowledge of patients, or anecdotal data. Applications must include preliminary and/or published data that are relevant to NF and the proposed research project.Distinctive Features: This award mechanism offers two funding levels based on participation in two optional features:• Open Science Initiative: Catalyzes research for neurofibromatosis through early access to data and data sharing within the neurofibromatosis community.• Optional Qualified Collaborator: Encourages collaborative research between basic scientists and clinical researchers, and between academic and biotechnology scientists.The funding levels are defined as follows:• Level 1: Applications without an optional feature.• Level 2: Applications including one of the optional features.

Summary: The fiscal year 2026 (FY26) Neurofibromatosis Research Program (NFRP) Exploration-Hypothesis Development Award (EHDA) supports the initial exploration of innovative, high-risk, high-gain, and potentially groundbreaking concepts in neurofibromatosis (NF) research. Studies supported by this award mechanism should lay the groundwork for future avenues of scientific investigation. The proposed research project should include a well-formulated, testable hypothesis based on strong scientific rationale and study design.Distinctive Features:• Innovation: The proposed research project should be innovative. Innovative research may introduce a novel paradigm, challenge existing paradigms, examine existing problems from novel perspectives, or exhibit other highly creative qualities.• Preliminary Data: Preliminary and/or published data is encouraged but not required.

Summary: The fiscal year 2026 (FY26) Neurofibromatosis Research Program (NFRP) Synergistic Idea Award (SIA) supports new ideas that represent synergistic approaches to neurofibromatosis (NF) research involving two or three Principal Investigators (PIs). These investigators should utilize their complementary and synergistic perspectives to address a central problem or question in NF research. Applications must include preliminary and/or published data that are relevant to NF and the proposed research project.Distinctive Features:• Partnering Principal Investigators: One PI will be identified as the Initiating PI and will be responsible for the majority of the administrative tasks associated with application submission. An additional one or two PI(s) will be identified as a Partnering PI. Each partner will be recognized as a PI, submit a separate application (even if the partners are at the same organization), and receive an individual award.

Expected Impact:The LIFE operating grants for non-profit making entities aim to strengthen the participation of civil society in the EU policy dialogue, as well as to support implementation and enforcement of Union environmental and climate objectives, including the clean energy transition, by the beneficiaries.Objective:This call for proposals concerns LIFE Specific Operating Grant Agreements (SGA OG) . LIFE Specific Operating Grant Agreements will only be concluded with organisations that have successfully signed a LIFE 2026 Operating Grant Framework Partnership Agreements (FPA OG).Framework Partnership Agreements (FPAs) under the LIFE Programme are long-term cooperation instruments that serve as umbrella for regular or recurrent grants to non-profit making entities which are involved in the development, implementation and enforcement of EU legislation and policy and which are primaril...

Scope:Provides financial support for the preparation of a proposal for a Strategic Integrated Project (SIP) under the sub-programme for Climate Change Mitigation and Adaptation in order to implement one of the following- National Energy and Climate Plans (NECP) including Long-Term Strategies (LTS), Regulation on the governance of the energy union and climate action (EU)2018/1999, - National adaptation strategies and plans pursuant to Article 5 of the Regulation 2021/1119 (‘European Climate Law’), or regional adaptation strategies or action plans, - Urban or community-based action plans pioneering the transition to a climate neutral and/or climate resilient society, including climate-neutral cities plans and actions, for instance in the context of the EU Mission ‘Climate neutral and smart cities’ and Sustainable Urban Mobility Plans, and - National, regional or industry-/sector-specific g...

Scope:Provides financial support for the preparation of a proposal for a Strategic Integrated Project (SIP) under the sub-programme Circular Economy and Quality of Life in the areas of Circular Economy, Waste, Water and Air, in order to implement- National or regional Circular Economy Action Plans, National and regional Waste Management Plans, River Basin Management Plans, Air Quality Plans or Noise Action Plans- at large territorial scale- with the involvement of all concerned stakeholders and- including a coordination mechanism for funding supporting complementary measures necessary for the full implementation of the targeted plan or strategy.

Scope:Provides financial support for the preparation of a proposal for a Strategic Nature Project (SNaP) to implement- a Priority Action Framework (PAF), National Restoration Plans, or other plans or strategies on international, national, regional or multiregional level that implement EU nature and/or biodiversity policy or legislation- at large territorial scale- with the involvement of all concerned stakeholders and- including a coordination mechanism for funding supporting complementary measures necessary for the full implementation of the targeted PAF (or other eligible strategy).

Expected Outcome:Efficient delivery of the quantified objectives by the end of the project.Objective:Projects under the Climate Change Mitigation Priority Area will support the implementation of the European Green Deal by contributing to the objectives and targets set out in the EU Climate Law and to the intermediate Union climate target to reduce net greenhouse gas emissions by at least 55% compared to 1990 levels by 2030.Scope: Areas of intervention: Recovery, recycle and reclamation of ozone-depleting substances in foams and suitability of alternatives to fluorinated greenhouse gases and their recovery, reclamation and recycling;Actions to support the shift to zero-emission mobility in road transport;Decarbonising other transport modes, fostering intermodality and modal shift;Increase the generation and use of renewable energy and improvement of energy efficiency;Actions which reduce...

Expected Outcome:Efficient delivery of the quantified objectives by the end of the project.Objective:Projects under this strand should help to achieve the long-term vision of the new EU Strategy on Adaptation to Climate Change that, in 2050, the EU will be a climate-resilient society which is fully adapted to the unavoidable impacts of climate change. Projects should help to reinforce adaptive capacity, strengthen resilience, and reduce vulnerability, in line with the Paris Agreement and the European Climate Law.Scope:Areas of Intervention:Support to the implementation of climate adaptation policies and the revision of national, regional or local climate adaptation strategies and plans;Implementing state-of-the-art tools for climate risk assessments or selection of cost-effective adaptation measures for dealing with climate threats and solutions for adaptation;Development and implementat...

Expected Outcome: Efficient delivery of the quantified objectives by the end of the project. Objective:LIFE Climate Change Governance and Information aims at supporting the development, implementation, monitoring and enforcement of the Union legislation and policy on climate change, contributing to climate change mitigation and/or adaptation. This includes improving governance through enhancing the capacities of public and private actors and the involvement of civil society.Scope: Areas of Intervention: Raising awareness, incentivising behavioural change and supporting the activities of the European Climate Pact;Green skills & capacity building to implement climate mitigation and adaptation policies;Building capacity, raising awareness among end-users and the equipment distribution chain of fluorinated greenhouse gases;Support to the development, update and implementation of national, re...